NGFR and acute lymphoblastic leukemia: Similar to CHMP5-deficient human T-ALL cells above (Figures 1A and 1B), unbiased pathway analysis of these DEGs also revealed marked downregulation of “MYC targets” in CD45.2+NGFR+ cells from KO T-ALL animals (Figures 6E and 6F).